Tags |
|
|
Links |
|
|
Advice You - FTC Says it Uses Whois Data Base to Catch Criminals
The Federal Trade Commission is upset that the Whosis Data Base
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
lock-outs for only $9.00 per year when websites renew their do
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
ain names is hurting their ability to track down criminals. The
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
Federal Trade Commission claims it has used the Whois database
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
to catch, convict and stop spammers, phishers and spyware culpr
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
ts.
Unfortunately the Federal Trade Commission has also doctor
Unfortunately the Federal Trade Commission has also doctor
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
d up sworn declarations, lied in their own declarations under o
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
ath and filed these bogus cases with malice and misrepresentati
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
n in Federal Courts. (We have legal proof of that statement).
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
evertheless, the Federal Trade Commission contends that it need
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
this information to protect consumers? Although some say that
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
the FTC has never protected consumers only put out public relat
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
ons pieces that it has. In fact spam has went up since the FTC
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
tarted going after spammers.
Recently in Federal Trade Commiss
Recently in Federal Trade Commiss
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
ion stated in a ICANN conference in Morocco [yah, must be nice
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
raveling on the taxpayers money!] that if they did not have use
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
of the database they would not be able to catch spammers of Int
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
ernet Fraudsters. Some people so distrust the Federal Trade Co
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
mission they actually have said that the FTC is the fraudulent
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
roup and the reason for the Spammers. Consider all this in 2006
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.adviceyou.org.ua/article/59320/adviceyou-FTC-Says-it-Uses-Whois-Data-Base-to-Catch-Criminals.html">FTC Says it Uses Whois Data Base to Catch Criminals</a>
BB link (for phorums):
[url=http://www.adviceyou.org.ua/article/59320/adviceyou-FTC-Says-it-Uses-Whois-Data-Base-to-Catch-Criminals.html]FTC Says it Uses Whois Data Base to Catch Criminals[/url]
Related Articles:
Set the Rules to Win the Game of Business
Management in Your Business Means Protecting Information
Bookmark it:
|